Pigna will explore GTN strategy, process, and readiness – along with a timeline – for Life Sciences manufacturers readying for their first commercial launch. “Gross-to-net accuracy, confidence, and ...

Revenue: $180.2 million, down 2% from the prior year. Adjusted EBITDA: $16.6 million, decreased from $22.3 million in FY24. Net Profit After Tax (NPAT): Loss of $6.1 million, compared to a loss of ...

Sharpe will host and moderate a roundtable discussion for the members of the Revenue Analytics Collaborative, a private, anonymous network of business and financial professionals, who own, support, ...

First quarter net product revenues for ZORYVE® franchise of $21.6M, with $15M for ZORYVE (roflumilast) cream 0.3%, and $6.5M for ZORYVE (roflumilast) topical foam, 0.3%; sales growth of 675% vs. Q1 ...

PHILADELPHIA, May 6, 2021 /PRNewswire/ — IntegriChain, delivering Life Sciences’ only comprehensive data and business process platform for market access, today announced that Jen Sharpe, a ...

This fireside chat-oriented session will offer a glimpse into the mind of a C-suite executive, underscoring the role of GTN accuracy and proficiency to the broader business. This panel of industry ...

“Gross-to-net accuracy, confidence, and timeliness are hampered by siloed data and far too much manual toil,” said Sharpe. “Innovative teams such as those at Ironshore Therapeutics, Agile Therapeutics ...